16:30 IST
NSE
Business Update
Alkem Laboratories Business Update
Alkem Laboratories announced the US FDA classified its Amaliya, Daman facility as 'Official Action Indicated'. Operations continue at the site.
Alkem Laboratories Ltd
Alkem Laboratories Ltd news stories on ALFA NewsRead the news →- Share price
- ₹5,350.50
- Market cap
- ₹63,973 Cr
- Revenue (annual)
- ₹14,712 Cr
- Net profit (annual)
- ₹2,302 Cr
- P/E (TTM)
- 29.6×Sector 47.3×
- Promoter holding
- 49.70%-1.50% QoQ
- FII holding
- 10.42%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Management Change 7Merger & Restructuring 6Financial Results 6Product Launch 4Legal & Regulatory 4Business Update 4Other Announcement 3Annual General Meeting 3Results Update 2Earnings Call 2Board Meeting Date 2Results Correction 1Dividend 1Debt & Borrowing 1Capital Structure Change 1Capacity Expansion 1Board Meeting Outcome 1
Time
4 announcements with these filters
20:39 IST
NSE
Business Update
Alkem Laboratories Business Update
Alkem Laboratories Limited has filed its Business Responsibility and Sustainability Report (BRSR) for the financial year ended 31st March, 2026.
18:22 IST
BSE
Business Update
Alkem Laboratories Business Update
Alkem Laboratories' Taloja CRO facility successfully cleared an unannounced US FDA inspection. No Form 483 observations were issued, confirming compliance with international regulatory standards.
12:52 IST
NSE
Business Update
Alkem Laboratories Business Update
Alkem Laboratories Limited's manufacturing facility in Amaliya, Daman, underwent a US FDA inspection from April 20 to May 1, 2026. The company received Form 483 with seven observations and intends to address them within the stipulated timeframe. This is a routine regulatory update regarding facility compliance.